Stocktoria
Aptevo Therapeutics Inc. APVO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-07-20
Aptevo Therapeutics Inc. statistics & valuation
Market cap$5.7M
P / B0.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | -919.7% | -174.1% |
| Net margin | — | — | — | 257.8% | -231.5% |
| FCF margin | — | — | — | -676.0% | -182.2% |
| Return on assets | -95.5% | -154.8% | -70.1% | 23.5% | -50.3% |
| Return on equity | -149.4% | -507.5% | -142.5% | 44.7% | -2340.2% |
| Debt / equity | — | — | 0.00× | 0.22× | 13.17× |
| Current ratio | 3.82 | 1.72 | 2.64 | 3.15 | 1.51 |
| Revenue growth | — | — | — | -74.7% | 185.3% |
Source: SEC EDGAR filings · CIK 0001671584 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.